Abiteron Tablet

About Abiteron 250 mg Tablet

Made by One Pharma Ltd., Abiteron is a tablet whose active ingredient is Abiraterone Acetate. It is not for use in women or children.

There are 4 brands of Abiraterone Acetate listed in Bangladesh. The lowest listed price is Abiret 250 mg Tablet at ৳ 500.00 per unit.

What is Abiteron 250 mg Tablet?

Abiteron is a tablet from One Pharma Ltd., with the generic name Abiraterone Acetate. It blocks an enzyme in the body that makes androgens, the male hormones that can encourage prostate cancer cells to grow. Doctors use it as part of treatment for certain stages of prostate cancer, always alongside other medicines and under specialist supervision. Whether it suits you is a decision for your doctor.

Uses of Abiteron

It is not for use in women or children. It is given together with prednisone and, where appropriate, another hormone treatment or after surgery to remove the testes. Patients should also receive a GnRH analog or have had bilateral orchiectomy. Your doctor will confirm whether this treatment is suitable for your condition.

How to use Abiteron

Swallow the tablet whole with water; do not crush or chew it. Abiteron is taken by mouth. It can be taken with or without food. Always follow your doctor's instructions and keep all appointments for monitoring. If you miss a dose or are unsure, ask your doctor or pharmacist rather than adjusting it yourself.

Side effects of Abiteron

Common side effects include fatigue, joint pain, high blood pressure, nausea, swelling, low potassium, hot flushes, diarrhoea, vomiting, upper respiratory infection, cough, and headache. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.

Safety and precautions

Before starting Abiteron 250 mg tablet, tell your doctor about heart disease, high blood pressure, low potassium, liver problems or any past adrenal problems, because these need close monitoring. Abiteron is not for use in women, and its safety in pregnancy and breastfeeding has not been established. Before starting, tell your doctor if you have heart disease, high blood pressure, low potassium, liver problems, or are taking other medicines, as dose changes may be needed. Keep out of reach of children.

Frequently asked questions

What does Abiteron treat?

It is not for use in women or children. It is given together with prednisone and, where appropriate, another hormone treatment or after surgery to remove the testes.

How is Abiteron used?

Swallow the tablet whole with water; do not crush or chew it. Abiteron is taken by mouth.

What should I watch for while using Abiteron?

Common side effects include fatigue, joint pain, high blood pressure, nausea, swelling, low potassium, hot flushes, diarrhoea, vomiting, upper respiratory infection, cough, and headache. Tell your doctor if any side effect bothers you or does not go away.

Who should be careful with Abiteron?

Before starting Abiteron 250 mg tablet, tell your doctor about heart disease, high blood pressure, low potassium, liver problems or any past adrenal problems, because these need close monitoring. Abiteron is not for use in women, and its safety in pregnancy and breastfeeding has not been established.

Indications

Abiraterone Acetate is a CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with
  • Metastatic castration-resistant prostate cancer (CRPC).
  • Metastatic high-risk castration-sensitive prostate cancer (CSPC).

Pharmacology

Abiraterone is an orally active inhibitor of the steroidal enzyme CYP17A1 (17 alpha-hydroxylase/C17,20 lyase). It inhibits CYP17A1 in a selective and irreversible manner via covalent binding mechanism. CYP17A1 is an enzyme that catalyzes the biosynthesis of androgen and is highly expressed in testicular, adrenal, and prostatic tumor tissue. More specifically, abiraterone inhibits the conversion of 17-hydroxyprognenolone to dehydroepiandrosterone (DHEA) by the enzyme CYP17A1 to decrease serum levels of testosterone and other androgens.

Dosage & Administration

Metastatic castration-resistant prostate cancer: Abiraterone 1,000 mg orally once daily with prednisone 5 mg orally twice daily.

Metastatic castration-sensitive prostate cancer: Abiraterone 1,000 mg orally once daily with prednisone 5 mg orally once daily.

Patients receiving Abiraterone should also receive a gonadotropin-releasing hormone (GnRH) analog concurrently or should have had bilateral orchiectomy. Abiraterone must be taken on an empty stomach with water at least 1 hour before or 2 hours after a meal. Do not crush or chew tablets.

Dose Modification:
  • For patients with baseline moderate hepatic impairment (Child-Pugh Class B), reduce the Abiraterone starting dose to 250 mg once daily.
  • For patients who develop hepatotoxicity during treatment, hold Abiraterone until recovery. Retreatment may be initiated at a reduced dose. Abiraterone should be discontinued if patients develop severe hepatotoxicity.

Interaction

CYP3A4 Inducers: Avoid concomitant strong CYP3A4 inducers during Abiraterone treatment. If a strong CYP3A4 inducer must be co-administered, increase the Abiraterone dosing frequency.

CYP2D6 Substrates: Avoid co-administration of Abiraterone with CYP2D6 substrates that have a narrow therapeutic index. If an alternative treatment cannot be used, exercise caution and consider a dose reduction of the concomitant CYP2D6 substrate.

Contraindications

Hypersensitivity to the Abiraterone acetate or to any of the excipients of Abiraterone.

Side Effects

The most common adverse reactions are fatigue, arthralgia, hypertension, nausea, edema, hypokalemia, hot flush, diarrhea, vomiting, upper respiratory infection, cough, and headache.

Pregnancy & Lactation

The safety and efficacy of Abiraterone have not been established in females. Based on findings from animal studies and the mechanism of action, Abiraterone can cause fetal harm and potential loss of pregnancy. There are no human data on the use of Abiraterone in pregnant women. The safety and efficacy of Abiraterone have not been established in females. There is no information available on the presence of abiraterone acetate in human milk, or on the effects on the breastfed child or milk production.

Precautions & Warnings

Mineralocorticoid excess: Closely monitor patients with cardiovascular disease. Control hypertension and correct hypokalemia before treatment. Monitor blood pressure, serum potassium and symptoms of fluid retention at least monthly.

Adrenocortical insufficiency: Monitor for symptoms and signs of adrenocortical insufficiency. Increased dosage of corticosteroids may be indicated before, during and after stressful situations.

Hepatotoxicity: Can be severe and fatal. Monitor liver function and modify, interrupt, or discontinue Abiraterone dosing as recommended.

Increased fractures and mortality in combination with radium Ra 223 dichloride: Use of Abiraterone plus prednisone/prednisolone in combination with radium Ra 223 dichloride is not recommended.

Embryo-Fetal Toxicity: Abiraterone can cause fetal harm. Advise males with female partners of reproductive potential to use effective contraception.

Overdose Effects

Human experience of overdose with Abiraterone is limited. There is no specific antidote. In the event of an overdose, stop Abiraterone, undertake general supportive measures, including monitoring for arrhythmias and cardiac failure and assess liver function.

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Alternative brands of Abiraterone Acetate

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.